Park W - Search Results

1

Mitochondria-associated programmed cell death as a therapeutic target for age-related disease.

Nguyen TT, Wei S, Nguyen TH, Jo Y, Zhang Y, Park W, Gariani K, Oh CM, Kim HH, Ha KT, Park KS, Park R, Lee IK, Shong M, Houtkooper RH, Ryu D. Nguyen TT, et al. Among authors: park r, park ks, park w. Exp Mol Med. 2023 Aug;55(8):1595-1619. doi: 10.1038/s12276-023-01046-5. Epub 2023 Aug 23. Exp Mol Med. 2023. PMID: 37612409 Free PMC article. Review.

2

Diversity and complexity of cell death: a historical review.

Park W, Wei S, Kim BS, Kim B, Bae SJ, Chae YC, Ryu D, Ha KT. Park W, et al. Exp Mol Med. 2023 Aug;55(8):1573-1594. doi: 10.1038/s12276-023-01078-x. Epub 2023 Aug 23. Exp Mol Med. 2023. PMID: 37612413 Free PMC article. Review.

3

Integrative Evaluation of the Clinical Significance Underlying Protein Arginine Methyltransferases in Hepatocellular Carcinoma.

Jiang Y, Wei S, Koo JM, Kim HJ, Park W, Zhang Y, Guo H, Ha KT, Oh CM, Kang JS, Jeong JH, Ryu D, Kim KJ, Jo Y. Jiang Y, et al. Among authors: park w. Cancers (Basel). 2023 Aug 20;15(16):4183. doi: 10.3390/cancers15164183. Cancers (Basel). 2023. PMID: 37627211 Free PMC article.

4

Author Correction: Diversity and complexity of cell death: a historical review.

Park W, Wei S, Kim BS, Kim B, Bae SJ, Chae YC, Ryu D, Ha KT. Park W, et al. Exp Mol Med. 2023 Sep;55(9):2083. doi: 10.1038/s12276-023-01107-9. Exp Mol Med. 2023. PMID: 37731035 Free PMC article. No abstract available.

5

Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.

Han JH, Lee EJ, Park W, Ha KT, Chung HS. Han JH, et al. Among authors: park w. Front Pharmacol. 2023 Oct 17;14:1275000. doi: 10.3389/fphar.2023.1275000. eCollection 2023. Front Pharmacol. 2023. PMID: 37915411 Free PMC article. Review.

6

Cosmosiin Induces Apoptosis in Colorectal Cancer by Inhibiting PD-L1 Expression and Inducing ROS.

Han JH, Lee EJ, Park W, Choi JG, Ha KT, Chung HS. Han JH, et al. Among authors: park w. Antioxidants (Basel). 2023 Dec 18;12(12):2131. doi: 10.3390/antiox12122131. Antioxidants (Basel). 2023. PMID: 38136250 Free PMC article.

7

Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Park W, Han JH, Wei S, Yang ES, Cheon SY, Bae SJ, Ryu D, Chung HS, Ha KT. Park W, et al. Int J Mol Sci. 2024 Jan 9;25(2):807. doi: 10.3390/ijms25020807. Int J Mol Sci. 2024. PMID: 38255882 Free PMC article. Review.

8

CDKN2 expression is a potential biomarker for T cell exhaustion in hepatocellular carcinoma.

Wei S, Zhang Y, Kang BE, Park W, Guo H, Nam S, Kang JS, Jeong JH, Jo Y, Ryu D, Jiang Y, Ha KT. Wei S, et al. Among authors: park w. BMB Rep. 2024 Mar 25:6113. Online ahead of print. BMB Rep. 2024. PMID: 38523373 Free article.

9

Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer.

Park W, Wei S, Xie CL, Han JH, Kim BS, Kim B, Jin JS, Yang ES, Cho MK, Ryu D, Yang HX, Bae SJ, Ha KT. Park W, et al. Exp Mol Med. 2024 May 1. doi: 10.1038/s12276-024-01221-2. Online ahead of print. Exp Mol Med. 2024. PMID: 38689087 Free article.

10

Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value.

Kim A, Lee SJ, Kim YK, Park WY, Park DY, Kim JY, Lee CH, Gong G, Huh GY, Choi KU. Kim A, et al. Sci Rep. 2017 Sep 15;7(1):11671. doi: 10.1038/s41598-017-11905-7. Sci Rep. 2017. PMID: 28916815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,737 results

Search Page